Literature DB >> 28008787

A review of dose-responses of probiotics in human studies.

A C Ouwehand1.   

Abstract

The probiotic definition requires the administration of an 'adequate amount' in order to obtain a health benefit. What that amount should be is not indicated. Here, an overview is given of studies that investigated the dose-response relation of probiotics in human interventions. Studies were divided in; meta-analyses, meta-analyses on specific probiotic strains, and studies testing two or more doses of a probiotic (combination) in the same study. Meta-analyses on the effect of probiotics on antibiotic associated diarrhoea (AAD) suggest a dose-response effect; for Clostridium difficile-associated diarrhoea on the other hand no dose-response was observed. For other end-points; such as necrotising enterocolitis, prevention of atopic dermatitis and slow intestinal transit, no dose-response relation was identified in meta-analyses. For prophylaxis in colorectal cancer and relief of irritable bowel syndrome, no dose-response relation was determined. However, for blood pressure, a meta-analysis observed that higher doses (greater than 1011 cfu) were more effective than lower doses. Meta-analyses of specific strains suggest a break-point for effectiveness of Lactobacillus rhamnosus GG in the treatment of acute gastroenteritis in children; no dose-response was observed for two other probiotics assessed. Studies comparing two or more doses indicate that faecal recovery and risk reduction of AAD follow a positive dose-response relationship. Other end-points such as immune markers, general health, and bowel function did not exhibit clear dose-response relations. For AAD, the findings are very compelling; both meta-analyses and dedicated dose-response studies observe a positive correlation between dose and AAD risk. These findings do not allow for extrapolation, but suggest that studying higher doses for this end-point would be worthwhile. The lack of a clear dose-response for other end-points, does not mean it does not exist; present data does just not allow drawing any conclusions.

Entities:  

Keywords:  Bifidobacterium; Lactobacillus; antibiotic associated diarrhoea; dose-response

Mesh:

Substances:

Year:  2016        PMID: 28008787     DOI: 10.3920/BM2016.0140

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  40 in total

1.  Safety Assessment of Potential Probiotic Lactobacillus fermentum MTCC-5898 in Murine Model after Repetitive Dose for 28 Days (Sub-Acute Exposure).

Authors:  Mrinal Samtiya; Mohd Iqbal Bhat; Taruna Gupta; Suman Kapila; Rajeev Kapila
Journal:  Probiotics Antimicrob Proteins       Date:  2020-03       Impact factor: 4.609

Review 2.  Probiotics' effect on visceral and subcutaneous adipose tissue: a systematic review of randomized controlled trials.

Authors:  Leonardo M Porchia; Gabriela Vazquez-Marroquin; Renata Ochoa-Précoma; Ricardo Pérez-Fuentes; M Elba Gonzalez-Mejia
Journal:  Eur J Clin Nutr       Date:  2022-04-13       Impact factor: 4.016

3.  Evaluation of the therapeutic effect and dose-effect of Bifidobacterium breve on the primary Clostridioides difficile infected mice.

Authors:  Jingpeng Yang; Hong Yang
Journal:  Appl Microbiol Biotechnol       Date:  2021-11-09       Impact factor: 4.813

4.  Quantifying and Engineering Mucus Adhesion of Probiotics.

Authors:  Zachary J S Mays; Todd C Chappell; Nikhil U Nair
Journal:  ACS Synth Biol       Date:  2020-01-13       Impact factor: 5.110

5.  Spray-drying microencapsulation using whey protein isolate and nano-crystalline starch for enhancing the survivability and stability of Lactobacillus reuteri TF-7.

Authors:  Narathip Puttarat; Suppasin Thangrongthong; Kittiwut Kasemwong; Paramaporn Kerdsup; Malai Taweechotipatr
Journal:  Food Sci Biotechnol       Date:  2021-02-06       Impact factor: 2.391

Review 6.  Probiotics and the Treatment of Parkinson's Disease: An Update.

Authors:  Hamed Mirzaei; Saman Sedighi; Ebrahim Kouchaki; Erfaneh Barati; Ehsan Dadgostar; Michael Aschner; Omid Reza Tamtaji
Journal:  Cell Mol Neurobiol       Date:  2021-07-20       Impact factor: 4.231

7.  Probiotics for the prevention of pediatric antibiotic-associated diarrhea.

Authors:  Qin Guo; Joshua Z Goldenberg; Claire Humphrey; Regina El Dib; Bradley C Johnston
Journal:  Cochrane Database Syst Rev       Date:  2019-04-30

Review 8.  Exploring the Role and Potential of Probiotics in the Field of Mental Health: Major Depressive Disorder.

Authors:  Dinyadarshini Johnson; Sivakumar Thurairajasingam; Vengadesh Letchumanan; Kok-Gan Chan; Learn-Han Lee
Journal:  Nutrients       Date:  2021-05-20       Impact factor: 5.717

Review 9.  Next Generation Probiotics for Neutralizing Obesogenic Effects: Taxa Culturing Searching Strategies.

Authors:  Ana López-Moreno; Inmaculada Acuña; Alfonso Torres-Sánchez; Ángel Ruiz-Moreno; Klara Cerk; Ana Rivas; Antonio Suárez; Mercedes Monteoliva-Sánchez; Margarita Aguilera
Journal:  Nutrients       Date:  2021-05-12       Impact factor: 5.717

Review 10.  Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Outpatients-A Systematic Review and Meta-Analysis.

Authors:  Sara Blaabjerg; Daniel Maribo Artzi; Rune Aabenhus
Journal:  Antibiotics (Basel)       Date:  2017-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.